98 related articles for article (PubMed ID: 25441337)
1. Novel Role of T Cells and IL-6 (Interleukin-6) in Angiotensin II-Induced Microvascular Dysfunction.
Senchenkova EY; Russell J; Yildirim A; Granger DN; Gavins FNE
Hypertension; 2019 Apr; 73(4):829-838. PubMed ID: 30739537
[TBL] [Abstract][Full Text] [Related]
2. Toll-like Receptor 4 Deficiency Reduces Oxidative Stress and Macrophage Mediated Inflammation in Hypertensive Kidney.
Pushpakumar S; Ren L; Kundu S; Gamon A; Tyagi SC; Sen U
Sci Rep; 2017 Jul; 7(1):6349. PubMed ID: 28743964
[TBL] [Abstract][Full Text] [Related]
3. Role of the Immune System in Hypertension.
Rodriguez-Iturbe B; Pons H; Johnson RJ
Physiol Rev; 2017 Jul; 97(3):1127-1164. PubMed ID: 28566539
[TBL] [Abstract][Full Text] [Related]
4. Immune cells and hypertension.
Gan L; Ye D; Feng Y; Pan H; Lu X; Wan J; Ye J
Immunol Res; 2024 Feb; 72(1):1-13. PubMed ID: 38044398
[TBL] [Abstract][Full Text] [Related]
5. Vasorelaxant Activities and its Underlying Mechanisms of Magnolia Volatile Oil on Rat Thoracic Aorta Based on Network Pharmacology.
Xu JF; Xia J; Wan Y; Yang Y; Wu JJ; Peng C; Ao H
Front Pharmacol; 2022; 13():812716. PubMed ID: 35308213
[No Abstract] [Full Text] [Related]
6. Potential mechanisms of Guizhi decoction against hypertension based on network pharmacology and Dahl salt-sensitive rat model.
Chen J; Zhang Y; Wang Y; Jiang P; Zhou G; Li Z; Yang J; Li X
Chin Med; 2021 Apr; 16(1):34. PubMed ID: 33906674
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the MiR-181b-5p/HMGB1 Pathway in Ang II-induced Phenotypic Transformation of Smooth Muscle Cells in Hypertension.
Li FJ; Zhang CL; Luo XJ; Peng J; Yang TL
Aging Dis; 2019 Apr; 10(2):231-248. PubMed ID: 31011475
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Ischemia Reperfusion Injury Following Instillation of 20 nm Citrate-capped Nanosilver.
Holland NA; Becak DP; Shannahan JH; Brown JM; Carratt SA; Winkle L; Pinkerton KE; Wang CM; Munusamy P; Baer DR; Sumner SJ; Fennell TR; Lust RM; Wingard CJ
J Nanomed Nanotechnol; 2015 Nov; 6(Suppl 6):. PubMed ID: 26966636
[TBL] [Abstract][Full Text] [Related]
9. Dual Activation of TRIF and MyD88 Adaptor Proteins by Angiotensin II Evokes Opposing Effects on Pressure, Cardiac Hypertrophy, and Inflammatory Gene Expression.
Singh MV; Cicha MZ; Meyerholz DK; Chapleau MW; Abboud FM
Hypertension; 2015 Sep; 66(3):647-56. PubMed ID: 26195481
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II as a pro-inflammatory mediator.
Phillips MI; Kagiyama S
Curr Opin Investig Drugs; 2002 Apr; 3(4):569-77. PubMed ID: 12090726
[TBL] [Abstract][Full Text] [Related]
11. The interplay between Angiotensin II, TLR4 and hypertension.
Biancardi VC; Bomfim GF; Reis WL; Al-Gassimi S; Nunes KP
Pharmacol Res; 2017 Jun; 120():88-96. PubMed ID: 28330785
[TBL] [Abstract][Full Text] [Related]
12. A role for innate immunity in the development of hypertension.
Gomolak JR; Didion SP
Med Hypotheses; 2014 Dec; 83(6):640-3. PubMed ID: 25441337
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.
Singh MV; Cicha MZ; Nunez S; Meyerholz DK; Chapleau MW; Abboud FM
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1027-H1038. PubMed ID: 30793936
[TBL] [Abstract][Full Text] [Related]
14. MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway.
Han J; Zou C; Mei L; Zhang Y; Qian Y; You S; Pan Y; Xu Z; Bai B; Huang W; Liang G
Basic Res Cardiol; 2017 Jan; 112(1):9. PubMed ID: 28013347
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MyD88 attenuates angiotensin II-induced hypertensive kidney disease via regulating renal inflammation.
Lin K; Luo W; Yang N; Su L; Zhou H; Hu X; Wang Y; Khan ZA; Huang W; Wu G; Liang G
Int Immunopharmacol; 2022 Nov; 112():109218. PubMed ID: 36116148
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
